London, March 12, 2024 (GLOBE NEWSWIRE) -- Global cell isolation market is flourishing and is projected to reach a value of US$10.1 Bn by the end of 2030, up from its 2022 size, i.e., US$4.1 Bn. Boasting an impressive CAGR of13.9% between 2023 and 2030, the market will continue to benefit largely from the rise of personalised medicine.
As cell isolation gains traction in thriving medical sectors like cancer treatment, regenerative medicine, and gene editing, the market is expected to see an exponential rate of growth over the years to come. Another factor propelling the market is the growing prevalence of chronic diseases like cancer, diabetes, and neurological disorders, marks the report.
Get Sample Copy of Report at: https://www.fairfieldmarketresearch.com/report/cell-isolation-market/request-sample
REPORT SCOPE
| Report Attributes | Details | |
| Base Year | 2022 | |
| Forecast Year | 2023 – 2030 | |
| Market Size in 2022 | US$4.1 Bn | |
| Estimated Market Size in 2030 | US$10.1 Bn | |
| CAGR | 13.9% | |
| Growth Drivers |
| |
| Segmentation |
| |
| Regional Coverage |
| |
“Cell isolation has a significant role to play in disease diagnosis, drug discovery, and cell-based therapies,” explains the company’s analyst, adding further, “New isolation methods are emerging, offering higher purity, viability, and yield of specific cell populations. Automation, and miniaturisation of cell isolation processes are also enhancing efficiency, and affordability”.
Despite a promising prospect, the regulatory hurdles, and prohibitive costs of some isolation techniques tend to impede wider adoption of the cell isolation technique. Additionally, ensuring the ethical sourcing and handling of cells remains a critical concern.
The future however appears bright. The demand for efficient and reliable cell isolation solutions will see a constant surge in the backdrop of technological advancements, and the increasing investments in this field. This will further propel market expansion, paving the way for breakthroughs in healthcare and personalised treatments.
For More Industry Insights Read: https://www.fairfieldmarketresearch.com/report/cell-isolation-market
Key Research Insights
- Reagents currently hold dominion in the cell isolation market.
Adoption by bio-research centres will be the maximum through 2030.
Key Asian markets reside in China, Japan, Korea, and India.
Insights into Segmentation Analysis
Reagents Reign Supreme with 50% Market Share
In 2022, reagents emerge as the undisputed champions of the cell isolation market, capturing nearly 50% of the total market share. Their versatility in isolating various cell types positions them as the preferred choice among researchers and clinicians.
Reagents play a fundamental role in various cell isolation techniques, offering high specificity and efficiency, essential for cutting-edge research and clinical applications.
Instruments Catapult Growth with an 8% Annual Surge
Advancements in technology propel the Instruments category to the forefront, displaying the fastest growth rate in the market.
Sophisticated instruments offer higher automation, precision, and throughput, meeting the escalating demand for high-throughput cell isolation.
With an average annual growth rate of approximately 8%, the Instruments category is reshaping the landscape of cell isolation, ushering in an era of unprecedented efficiency.
Bio-Research Centres Lead with 45% Market Share While Hospitals Accelerate
In 2022, bio-research centres emerged as the dominant application category, accounting for approximately 45% of the total market share.
These centres extensively leverage cell isolation techniques for diverse research purposes, fueling the demand for a wide range of cell isolation methods.
The consistent demand from bio-research centres underscores their dominance, with applications ranging from drug discovery to cancer and stem cell research.
Hospitals are all set for rapid growth at 10% rate annually.
Hospitals witness a notable surge in adopting cell isolation techniques, particularly in oncology and personalised medicine.
Precise cell analysis becomes imperative for diagnostics and treatment planning, driving the demand for cell isolation products in clinical settings.
Experiencing a rapid annual growth momentum of approximately 10%, the hospitals category signifies the expanding applications of cell isolation techniques beyond research settings.
Key Report Highlights
The market is witnessing a paradigm shift towards automation to meet the demands of high throughput, and reproducibility. Automated cell isolation systems are becoming integral in research and clinical labs, ensuring consistent results, and opening new avenues for exploration.As research delves deeper into rare cell populations, the focus on isolating these cells is intensifying. High-precision techniques like immunomagnetic separation and flow cytometry are gaining prominence, catering to the growing demand for isolating rare cells in diagnostics and research.Microfluidic-based cell isolation methods are gaining momentum due to their efficiency and low sample requirements. Companies worldwide are investing in miniaturised systems, ushering in a new era of precision in research applications.
Insights into Regional Analysis
The US Elevates North America
North America provides highly fertile ground for the expansion of the cell isolation market.
North America, particularly the US, emerges as a hub for biotechnological innovations, resulting in a high adoption rate of advanced cell isolation techniques.
The surge in research activities and technological advancements is propelling the region to the forefront of this transformative journey.
North America continues to lead the charge, contributing approximately 40% of the global cell isolation market share.
A well-established healthcare infrastructure, advanced research facilities, and a robust presence of biotechnology and pharmaceutical companies propel the region's dominance.
Strategic collaborations between academic research institutions, and leading industry players, coupled with government initiatives and funding, further reinforce North America's position as a continuous growth leader in the global cell isolation market.
China, Korea, Japan, and India at the Helm in Asia Pacific
Asia Pacific will experience surging growth in the years to come, with China, Japan, Korea, and India emerging as the star players.
The region has emerged as a powerhouse, poised for substantial sales growth in the cell isolation market. With an estimated market expansion, the region is set to become a key player in the global landscape.
A significant population base, notably increasing healthcare investments, and rapid expansion of medical research and healthcare services in countries like China, Japan, and India drive the demand for advanced cell isolation techniques.
Supportive government initiatives, funding for life sciences research, and collaborations between research institutions and biotechnology companies create a robust market environment, making Asia Pacific one of the primary revenue contributors in the global cell isolation market.
Key Players in Global Cell Isolation Market
- Beckman CoulterGE Healthcare
- Becton Dickinson and CompanyMiltenyi BiotecMerck KGaATerumo BCTSTEMCELL Technologies Inc.PluriSelect Life Science UG & Co. KGThermo Fisher ScientificCorning, Inc.DanaherBD BioscienceGenScript
Global Cell Isolation Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - (By Type Coverage, By Automation Coverage, By Geographic Coverage and By Company): https://www.fairfieldmarketresearch.com/report/cell-isolation-market About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness. Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
Web: https://www.fairfieldmarketresearch.com/
Email: sales@fairfieldmarketresearch.com
LinkedIn | Twitter
